Orphan drug status

This status is awarded for drugs by the Food and Drug Administration (FDA) in the USA and by the European Medicines Evaluation Agency. It grants exclusive marketing rights for seven years from approval in the USA and ten years in the EU

Seite gelesen: 669 | Heute: 3
Seite gelesen: 670 | Heute: 4